StonvexLoading…
StonvexStonvexStonvexCore line items from JBLU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.24B | $9.06B | $6.82B | $4.50B |
Operating Income | $-224.00M | $-368.00M | $-268.00M | $-168.00M |
Net Income | $-319.00M | $-602.00M | $-425.00M | $-282.00M |
EPS (Diluted) | $-0.86 | $-1.66 | $-1.18 | $-0.79 |
Total Assets | $16.61B | $16.57B | $16.60B | $16.90B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.86B | $1.95B | $2.41B | $2.13B |
Free Cash Flow OCF − CapEx | $-6.00M | $-1.17B | $-885.00M | $-474.00M |
Shares Outstanding | 372.00M | 370.00M | 364.00M | 364.00M |